Search Results - "Jacob, Sony"

Therapeutic Outlook of Pyrazole Analogs: A Mini Review by Ganguly, Swastika, Jacob, Sony K

“…Pyrazole is one of the excellent structural motifs in medicinal chemistry. Various physiological and therapeutic possibilities have been exploited by…”
Get more information

Homocysteine and Reclassification of Cardiovascular Disease Risk by Veeranna, Vikas, MD, Zalawadiya, Sandip K., MD, Niraj, Ashutosh, MD, MS, Pradhan, Jyotiranjan, MD, Ference, Brian, MD, MPhil, Burack, Robert C., MD, MPH, Jacob, Sony, MD, Afonso, Luis, MD

“…Objectives The purpose of this study was to examine whether adding homocysteine (Hcy) to a model based on traditional cardiovascular disease (CVD) risk factors…”
Get full text

Influence of Obesity on Outcomes in Atrial Fibrillation: Yet Another Obesity Paradox by Badheka, Apurva O., MD, Rathod, Ankit, MD, Kizilbash, Mohammad A., MD, Garg, Neha, MD, Mohamad, Tamam, MD, Afonso, Luis, MD, Jacob, Sony, MD

“…Abstract Background Obese patients have favorable outcomes in congestive heart failure, hypertension, peripheral vascular disease, and coronary artery disease…”
Get full text

Anaphylaxis and Hypotension after Administration of Peginesatide by Bennett, Charles L, Jacob, Sony, Hymes, Jeffrey, Usvyat, Len A, Maddux, Franklin W

“…This letter describes serious adverse events (three fatal cardiorespiratory arrests and two grade 4 anaphylaxis and hypotension events) related to the…”
Get full text

A BATTLE AGAINST AIDS: NEW PYRAZOLE KEY TO AN OLDER LOCK-REVERSE TRANSCRIPTASE by K., Sony Jacob, Ganguly, Swastika

“…Objective: The reason for the failure of most of the anti-HIV drugs are their poor pharmacokinetics, the poor risk to benefit ratio and the drug resistance…”
Get full text

Azithromycin and Levofloxacin Use and Increased Risk of Cardiac Arrhythmia and Death by Rao, Gowtham A., MD, PhD, MPH, Mann, Joshua R., MD, MPH, BPharm, Azza Shoaibi, MPH, Bennett, Charles Lee, MD, PhD, MPP, Nahhas, Georges, MPH, Sutton, S. Scott, PharmD, Jacob, Sony, MD, Strayer, Scott M., MD, MPH

“…Abstract Purpose Azithromycin use has been associated with increased risk of death among patients at high baseline risk, but not for younger and middle-aged…”
Get full text

A MHz X‐ray diffraction set‐up for dynamic compression experiments in the diamond anvil cell by Husband, Rachel J., Strohm, Cornelius, Appel, Karen, Ball, Orianna B., Briggs, Richard, Buchen, Johannes, Cerantola, Valerio, Chariton, Stella, Coleman, Amy L., Cynn, Hyunchae, Dattelbaum, Dana, Dwivedi, Anand, Eggert, Jon H., Ehm, Lars, Evans, William J., Glazyrin, Konstantin, Goncharov, Alexander F., Graafsma, Heinz, Howard, Alex, Huston, Larissa, Hutchinson, Trevor M., Hwang, Huijeong, Jacob, Sony, Kaa, Johannes, Kim, Jaeyong, Kim, Minseob, Koemets, Egor, Konôpková, Zuzana, Langenhorst, Falko, Laurus, Torsten, Li, Xinyang, Mainberger, Jona, Marquardt, Hauke, McBride, Emma E., McGuire, Christopher, McHardy, James D., McMahon, Malcolm I., McWilliams, R. Stewart, Méndez, Alba S. J., Mondal, Anshuman, Morard, Guillaume, O'Bannon, Earl F., Otzen, Christoph, Pépin, Charles M., Prakapenka, Vitali B., Prescher, Clemens, Preston, Thomas R., Redmer, Ronald, Roeper, Michael, Sanchez-Valle, Carmen, Smith, Dean, Smith, Raymond F., Sneed, Daniel, Speziale, Sergio, Spitzbart, Tobias, Stern, Stephan, Sturtevant, Blake T., Sztuk-Dambietz, Jolanta, Talkovski, Peter, Velisavljevic, Nenad, Vennari, Cara, Wu, Zhongyan, Yoo, Choong-Shik, Zastrau, Ulf, Jenei, Zsolt, Liermann, Hanns-Peter

“…An experimental platform for dynamic diamond anvil cell (dDAC) research has been developed at the High Energy Density (HED) Instrument at the European X‐ray…”
Get full text

The Efficacy of Sotalol in Preventing Postoperative Atrial Fibrillation: A Meta-Analysis by Kerin, Nicholas Z., MD, Jacob, Sony, MD

“…Abstract Objective Supraventricular tachyarrhythmias including atrial fibrillation are common and troubling complications after cardiac surgery, and thus…”
Get full text

Comparison of Mortality and Morbidity in Patients With Atrial Fibrillation and Heart Failure With Preserved Versus Decreased Left Ventricular Ejection Fraction by Badheka, Apurva O., MD, Rathod, Ankit, MD, Kizilbash, Mohammad A., MD, Bhardwaj, Aditya, MD, Ali, Omaima, MD, Afonso, Luis, MD, Jacob, Sony, MD

“…Almost 50% of patients with congestive heart failure (HF) have preserved ejection fraction (PEF). Data on the effect of HF-PEF on atrial fibrillation outcomes…”
Get full text

Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR) by Jacob, Sony, Dunn, Brianne L, Qureshi, Zaina P, Bandarenko, Nicholas, Kwaan, Hau C, Pandey, Dilip K, McKoy, June M, Barnato, Sara E, Winters, Jeffrey L, Cursio, John F, Weiss, Ivy, Raife, Thomas J, Carey, Patricia M, Sarode, Ravindra, Kiss, Joseph E, Danielson, Constance, Ortel, Thomas L, Clark, William F, Rock, Gail, Matsumoto, Masanori, Fujimura, Yoshihiro, Zheng, X Long, Chen, Hao, Chen, Fei, Armstrong, John M, Raisch, Dennis W, Bennett, Charles L

“…Thienopyridine-derivatives (ticlopidine, clopidogrel, and prasugrel) are the primary antiplatelet agents. Thrombotic thrombocytopenic purpura (TTP) is a rare…”
Get more information

Cardiac Rhythm Device Identification Algorithm using X-Rays: CaRDIA-X by Jacob, Sony, MD, Shahzad, Muhammad A., MD, Maheshwari, Rahul, BS, Panaich, Sidakpal S., MD, Aravindhakshan, Rajeev, MD

Get full text

Ticlopidine‐associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR) by Bennett, Charles L., Jacob, Sony, Dunn, Brianne L., Georgantopoulos, Peter, Zheng, X Long, Kwaan, Hau C., McKoy, June M., Magwood, Jametta S., Qureshi, Zaina P., Bandarenko, Nicholas, Winters, Jeffrey L., Raife, Thomas J., Carey, Patricia M., Sarode, Ravindra, Kiss, Joseph E., Danielson, Constance, Ortel, Thomas L., Clark, William F., Ablin, Richard J., Rock, Gail, Matsumoto, Masanori, Fujimura, Yoshihiro

Get full text

Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy by Jacob K., Sony, Ganguly, Swastika, Kumar, Pravin, Poddar, Raju, Kumar, Anoop

“…Candida albicans infections and their resistance to clinically approved azole drugs are major concerns for human. The azole antifungal drugs inhibit the…”
Get full text

Device Therapy in Heart Failure Patients With Chronic Kidney Disease by Badheka, Apurva, MD, Rathod, Ankit, MD, Tuliani, Tushar, MD, Afonso, Luis, MD, Jacob, Sony, MD

“…The use of ICDs was protective for secondary prevention of cardiac (but not all-cause) mortality in patients with renal disease. [...]cardiac mortality and not…”
Get full text

Obesity Paradox in Outcomes of Atrial Fibrillation by Badheka, Apurva O., MD, Rathod, Ankit, MD, Bharadwaj, Aditya, MD, Afonso, Luis, MD, Jacob, Sony, MD

Get full text

Usefulness of Microalbuminuria in Patients With the Metabolic Syndrome to Predict Subclinical Atherosclerosis and Cardiovascular Disease Outcomes by Afonso, Luis, MD, Hari, Pawan, MD, MPH, Kondur, Ashok, MD, Veeranna, Vikas, MD, Manickam, Palaniappan, MD, MPH, Simegn, Mengistu, MD, Jacob, Sony, MD, Ference, Brian, MD

“…The clinical implications of microalbuminuria (MA) in nondiabetic persons with the metabolic syndrome (MS) are largely unknown. The present post hoc analysis…”
Get full text

Impact of Lipid-Lowering Therapy on Outcomes in Atrial Fibrillation by Badheka, Apurva O., MD, Rathod, Ankit, MD, Kizilbash, Mohammad A., MD, Garg, Neha, MD, Mohamad, Tamam, MD, Afonso, Luis, MD, Jacob, Sony, MD

“…Lipid-lowering therapy (LLT) decreases mortality in select patient populations. LLT has also been shown to have antiarrhythmic effects, thus favorably…”
Get full text

Role of Lipid Lowering Therapy and Renin Angiotensin Blockade in Outcomes of Patients With Atrial Fibrillation by Badheka, Apurva O., MD, Tuliani, Tushar, MD, Rathod, Ankit, MD, Shenoy, Maithili, MD, MPH, Afonso, Luis, MD, Jacob, Sony, MD

Get full text

Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: Do novel lipid parameters offer an advantage? by Manickam, Palaniappan, MD, MPH, Rathod, Ankit, MD, Panaich, Sidakpal, MD, Hari, Pawan, MD, MPH, Veeranna, Vikas, MD, Badheka, Apurva, MD, Jacob, Sony, MD, Afonso, Luis, MD, FACC

“…Background Comparative data on the prognostic utility of novel lipid parameters vs. conventional lipid parameters in predicting coronary events are scant…”
Get full text

QRS Fragmentation in Patients With Repaired Tetralogy of Fallot by Jacob, Sony, MD, Agarwal, Kanishtha, MD, Afonso, Luis, MD

Get full text